AT
Akanksha Togra
About Akanksha Togra
Data last updated:
Akanksha Togra is a Director at Clinexel Life Sciences Private Limited (since 2019), Designated Partner at Cytenet Life Science Llp (since 2022) and Director at Glrk Healthcare Foundation (since 2021). The companies operate in Pharma, Information Technology and Non-Profit Organizations. The largest current company by reported revenue is Clinexel Life Sciences Private Limited at ₹5.42 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Clinexel Life Sciences Private Limited U74999MH2019PTC320241 | Director | 28 Jan 2019 | 2019 | ₹5.42 Cr (FY 2024) | Active |
 Cytenet Life Science Llp ABC-6695 | Designated Partner | 07 Oct 2022 | 2022 | Active | |
| Glrk Healthcare Foundation U85300MH2021NPL361027 | Director | 25 May 2021 | 2021 | Active |
Board colleagues of Akanksha Togra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepa Arora | 08344282 | Clinexel Life Sciences Private Limited , Cytenet Life Science Llp and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akanksha Togra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akanksha Togra
Akanksha Togra currently holds 3 directorships: Clinexel Life Sciences Private Limited (Director, since 28 Jan 2019, revenue ₹5.42 Cr (FY 2024)); Cytenet Life Science Llp (Designated Partner, since 07 Oct 2022); Glrk Healthcare Foundation (Director, since 25 May 2021).
Akanksha Togra was first appointed on 28 Jan 2019 as Director at Clinexel Life Sciences Private Limited. The most recent appointment on record is 07 Oct 2022 at Cytenet Life Science Llp.
The current boards of Akanksha Togra's companies include Deepa Arora (Clinexel Life Sciences Private Limited).